All News

As this issue of Urology Times went to press, passage of major health care reform legislation-on which AUA and other health care groups had devoted considerable time, energy, and resources-was in jeopardy.

Just a few years ago, it would have been unthinkable to offer testosterone therapy (TTh) to men with a history of prostate cancer. Yet several changes have occurred to make TTh a reasonable treatment option in men who are symptomatic from testosterone deficiency.

With a foundation of robotic surgery investigated and established for radical prostatectomy, urologists have now focused on expanding robotic applications to the upper tract. The most common examples are robotic partial nephrectomy and robotic pyeloplasty.

Michael Blute, MD, has joined UMass Memorial Health Care and UMass Medical School, Worcester, MA, as director of the Cancer Center of Excellence, professor of surgery, and interim director of the division of urology in the department of surgery.

Patients with metastatic prostate cancer who received a vaccine engineered to spur an immune system attack on prostate tumor cells lived substantially longer than patients who received a placebo vaccine, according to researchers at Dana-Farber Cancer Institute, Boston and affiliated organizations.

Androgen deprivation therapy (ADT) can worsen heart risk factors and may increase the risk of heart attack and/or cardiac death, although the relationship between ADT and heart attack or cardiac death has not been definitively established, according to a science advisory from a multi-organization group.

No matter the size of your practice, unless each physician is the same age and plans to retire at the same time, you should consider developing a transition plan for the senior doctors in your practice.